<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">53353</article-id><article-id pub-id-type="doi">10.7554/eLife.53353</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Activated α<sub>IIb</sub>β<sub>3</sub> on platelets mediates flow-dependent NETosis via SLC44A2</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-163738"><name><surname>Constantinescu-Bercu</surname><given-names>Adela</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1274-2867</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163739"><name><surname>Grassi</surname><given-names>Luigi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163740"><name><surname>Frontini</surname><given-names>Mattia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-163741"><name><surname>Salles-Crawley</surname><given-names>Isabelle I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-35869"><name><surname>Woollard</surname><given-names>Kevin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9839-5463</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-158504"><name><surname>Crawley</surname><given-names>James TB</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6723-7841</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Centre for Haematology, Department of Immunology and Inflammation</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Haematology</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Centre for Inflammatory Disease, Department of Immunology and Inflammation</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1090"><name><surname>Ginsburg</surname><given-names>David</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of Michigan</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>i.salles@imperial.ac.uk</email> (IS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>k.woollard@imperial.ac.uk</email> (KW);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>j.crawley@imperial.ac.uk</email> (JC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>04</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e53353</elocation-id><history><date date-type="received"><day>06</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Constantinescu-Bercu et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Constantinescu-Bercu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-53353-v1.pdf"/><abstract><p>Platelet-neutrophil interactions are important for innate immunity, but also contribute to the pathogenesis of deep vein thrombosis, myocardial infarction and stroke. Here we report that, under flow, von Willebrand factor/glycoprotein Iba-dependent platelet 'priming' induces integrin a<sub>IIb</sub>b<sub>3</sub> activation that, in turn, mediates neutrophil and T-cell binding. Binding of platelet a<sub>IIb</sub>b<sub>3</sub> to SLC44A2 on neutrophils leads to mechanosensitive-dependent production of highly prothrombotic neutrophil extracellular traps. A polymorphism in <italic>SLC44A2</italic> (rs2288904-A) present in 22% of the population causes an R154Q substitution in an extracellular loop of SLC44A2 that is protective against venous thrombosis results in severely impaired binding to both activated a<sub>IIb</sub>b<sub>3 </sub>and<sub> </sub>VWF-primed platelets. This was confirmed using neutrophils homozygous for the <italic>SLC44A2</italic> R154Q polymorphism. Taken together, these data reveal a previously unreported mode of platelet-neutrophil crosstalk, mechanosensitive NET production, and provide mechanistic insight into the protective effect of the <italic>SLC44A2</italic> rs2288904-A polymorphism in venous thrombosis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/15/65/32036</award-id><principal-award-recipient><name><surname>Salles-Crawley</surname><given-names>Isabelle I</given-names></name><name><surname>Woollard</surname><given-names>Kevin</given-names></name><name><surname>Crawley</surname><given-names>James TB</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>PG/17/22/32868</award-id><principal-award-recipient><name><surname>Salles-Crawley</surname><given-names>Isabelle I</given-names></name><name><surname>Woollard</surname><given-names>Kevin</given-names></name><name><surname>Crawley</surname><given-names>James TB</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/18/53/33863</award-id><principal-award-recipient><name><surname>Frontini</surname><given-names>Mattia</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Specific ethical approval was obtained from the Imperial College Research Ethics Committee (19IC5523) for drawing blood from healthy volunteers and genotyping these for the SLC44A2 SNP. Fresh blood was collected from consented healthy volunteers.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. The source data underlying Figs 1, 2, 3, 4, 5c, 6, 8,  and Figure 1, 3 and 7 Supplements are provided in separate 'Source Data' files.</p></sec><supplementary-material><ext-link xlink:href="elife-53353-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>